Drug firm Dr Reddy's Laboratories today said its consolidated net profit has gone up by 25.38% to Rs 262.74 crore for the first quarter ended June 30, 2011, over the same period previous fiscal.
The company had a net profit of Rs 209.55 crore in the same period previous fiscal, Dr Reddy's Laboratories said in a filing to the Bombay Stock Exchange (BSE).
The company's net income from sales and services stood at Rs 1,978.32 crore for the first quarter ended June 30, 2011, compared to Rs 1,683.13 crore for the same period previous fiscal.
On a standalone basis, the company reported a net profit of Rs 454.05 crore for the first quarter ended June 30, 2011, compared to Rs 244.48 crore in the same period previous fiscal.
The company's net sales stood at Rs 1,675.71 crore for the first quarter on a standalone basis, compared to Rs 1,256.22 crore in the same period previous fiscal.
During the quarter, the company launched 39 new generic products, filed 31 new product registrations and nine drug master files globally, it said.
Shares of Dr Reddy's Laboratories today closed at Rs 1,570 on the BSE in late afternoon trade, down 1.87 from its previous close.
